Largest biotech by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 biotech ranked by total debt, at DKK 371.8B, ahead of Gilead Sciences (DKK 169.8B) and Biogen (DKK 42.8B). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenDKK 371.8B
Median
DKK 4B
Combined market value
DKK 5.73T
Countries
5
Not ranked
13no total debt on file

Market values as of .

Largest biotech by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareDKK 371.8BDKK 1.66TDKK 3,060.28 1.85% down 34% up United States
2Gilead SciencesGILD · Health CareDKK 169.8BDKK 1.43TDKK 1,151.38 0.68% down 33% up United States
3BiogenBIIB · Health CareDKK 42.8BDKK 252.2BDKK 1,705.87 0.10% down 49% up United States
4Halozyme TherapeuticsHALO · Health CareDKK 14.6BDKK 74.4BDKK 652.56 0.13% down 37% up United States
5QiagenQGEN · Health CareDKK 11.3BDKK 69.9BDKK 338.28 0.13% down 12% up Netherlands
6ModernaMRNA · Health CareDKK 4BDKK 557.9BDKK 1,378.75 2.08% down 755% up United States
7RepligenRGEN · Health CareDKK 3.7BDKK 74.1BDKK 1,159.38 5.00% up 5% up United States
8Bio-TechneTECH · Health CareDKK 1.4BDKK 77.8BDKK 495.18 0.14% up 26% up United States
9Adaptive BiotechnologiesADPT · Health CareDKK 893.3MDKK 31.3BDKK 193.29 0.35% down 88% up United States
10Scholar Rock HoldingSRRK · Health CareDKK 678.9MDKK 39.1BDKK 320.51 4.43% up 14% up United States
11CG OncologyCGON · Health CareDKK 20.4MDKK 47.5BDKK 531.44 1.12% down 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 6.8085 DKK). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech rank first by total debt?

Amgen (DKK 371.8B), Gilead Sciences (DKK 169.8B) and Biogen (DKK 42.8B) are the top three of the 11 biotech ranked by total debt as of 18 Nov 2026, 14:51 UTC.

How many biotech are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech worth together?

The 11 biotech ranked by total debt have a combined market value of DKK 5.73T as of 18 Nov 2026, 14:51 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.